company

AKERSHUS BIOVARME AS

2030 NANNESTAD

Return on Equity
9,27 %
Current Ratio
2,04
Debt-to-Equity Ratio
2,09
Key figures (NOK)2022
Revenue829 000
Net Income71 000
Total Assets2 629 000
Total Equity766 000
Income (NOK)2022
Revenue829 000
Expenditure679 000
Operating Profit150 000
Financial Income1 000
Financial Costs60 000
Financial Balance−59 000
Earnings Before Tax91 000
Tax20 000
Net Income71 000
Balance (NOK)2022
Total Fixed Assets2 101 000
Total Current Assets528 000
Total Assets2 629 000
Total Retained Equity681 000
Total Equity766 000
Total Long-Term Debt1 604 000
Total Current Debt259 000
Total Equity and Debt2 629 000
Cash flow (NOK)2022
Sales Income829 000
Other Income0
Revenue829 000
Cost of Goods Sold273 000
Salary Costs0
Depreciation336 000
Impairment0
Expenditure679 000
Operating Profit150 000
Financial Income1 000
Financial Costs60 000
Financial Balance−59 000
Dividends0
Net Income71 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets88 000
Real Eastate2 010 000
Machinery and Plant Facilities0
Fixtures3 000
Total Tangible Assets2 013 000
Total Fiancial Fixed Assets0
Total Fixed Assets2 101 000
Stock0
Total Investments0
Cash, Bank442 000
Total Current Assets528 000
Total Assets2 629 000
Total Equity766 000
Short-Term Group Debt0
Total Long-Term Debt1 604 000
Creditors4 000
Unpaid Taxes31 000
Dividends0
Other Current Debt174 000
Total Current Debt259 000
Total Equity and Debt2 629 000
Financial indicators2022
Return on Equity9,27 %
Debt-to-Equity Ratio2,09
Operating Profit Margin18,09 %
Current Ratio2,04
Quick Ratio2,04
Equity Ratio0,29
Gross Profit Margin67,07 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English